Pathologic complete response to trastuzumab-based neoadjuvant therapy is related to the level of HER-2 amplification (Q81535280)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 November 2007
edit
Language Label Description Also known as
English
Pathologic complete response to trastuzumab-based neoadjuvant therapy is related to the level of HER-2 amplification
scientific article published on 01 November 2007

    Statements

    Pathologic complete response to trastuzumab-based neoadjuvant therapy is related to the level of HER-2 amplification (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit